Your browser doesn't support javascript.
loading
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Tohda, Yuji; Nakamura, Yoichi; Fujisawa, Takao; Ebisawa, Motohiro; Msihid, Jerome; Djandji, Michel; Ortiz, Benjamin; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J; Ishida, Masato; Arima, Kazuhiko.
Afiliación
  • Tohda Y; Kindai University Hospital, Osakasayama, Japan. Electronic address: tohda@med.kindai.ac.jp.
  • Nakamura Y; Yokohama City Minato Red Cross Hospital, Yokohama, Japan.
  • Fujisawa T; Allergy Center, National Hospital Organization Mie National Hospital, Tsu, Japan.
  • Ebisawa M; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Msihid J; Sanofi, Chilly-Mazarin, France.
  • Djandji M; Sanofi, Cambridge, MA, USA.
  • Ortiz B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Jacob-Nara JA; Sanofi, Bridgewater, NJ, USA.
  • Deniz Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Rowe PJ; Sanofi, Bridgewater, NJ, USA.
  • Ishida M; Sanofi, Tokyo, Japan.
  • Arima K; Sanofi, Tokyo, Japan.
Allergol Int ; 72(1): 89-99, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36114102
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article